Canada’s $6.2 Billion Lifeline Won’t Save Auto Stocks. A Court Case Might.
A Section 338 tariff lawsuit is the real variable for GM, Ford, and Stellantis.
The KOSPI Rout Has Reached Korea’s Central Bank
Something changed Thursday that most markets coverage will miss. The KOSPI fell 3.52% to 5,533.77. The Nikkei 225 dropped 2.65%…
One hour trading?
October 22, 2026 Bonus Content: NextDC’s $2 Billion Wipeout Starts With a Neighbourhood A note from our friends at Base…
Bitcoin Can’t Hold $85,000. ETF Outflows Explain Why.
BTC is about 34% below its October 2025 peak, and spot ETFs keep bleeding cash.
Tesla’s Recycling Plant Is Becoming Its Own Mine
With over 14,000 tons of batteries recycled in 2025 and a Texas refinery now operating, Tesla is building a materials pipeline few rivals can match quickly.
TSMC’s Construction Problem Is Bigger Than Four Deaths
The question investors are asking this morning is whether the tragedy at TSMC’s Kaohsiung site is a contained accident or…
Elon Musk: This Could be 180 Times Bigger than SpaceX IPO
October 21, 2026 Bonus Content: OpenAI Is Buying the Software That Runs Drug Trials A note from our friends at…
Boeing’s 737 MAX 10 Is Certified. 1,555 Orders Can Finally Ship.
FAA approval Tuesday turns parked jets into cash, with first deliveries targeted for 2027 and a backlog that is more than 30% of MAX orders.
The AI breakthrough hiding in Amazon’s warehouses
A note from our friends at The Oxford Club(ad) Dear Reader, Amazon built a robot that can “feel.” Not emotions…
Silence Therapeutics Got 130% Over Market. Now Institutions Are Pricing the Next RNA Bid.
Merck KGaA’s $1.3 billion all-cash deal arrived days after Beijing moved to curb foreign takeovers of Chinese siRNA platforms.